ArticleFrontiers in medicine2026
A Simplified non-invasive model based on albumin, bilirubin, and platelet count for predicting high-risk varices in compensated cirrhosis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Esophagogastroduodenoscopy (EGD) is the gold standard for detecting high-risk varices (HRV) in patients with liver cirrhosis, but is invasive and resource-intensive. The Albumin-Bilirubin-Platelet (ABP) model is non-invasive, but its performance requires validation in diverse populations. This study aimed to validate and refine the ABP criteria to predict HRV. Methods: This retrospective study included 474 patients with compensated cirrhosis, categorized into training ( Results: The prevalences of HRV were 15.96% and 20.42% in the training and validation cohorts, respectively. In multivariate analysis of the training cohort, only platelet count was an independent predictor of HRV ( Conclusion: The original ABP criteria provide a simple and safe strategy for identifying low-risk patients with compensated cirrhosis. The modified ABP criteria substantially improve endoscopy avoidance while maintaining acceptable safety, offering a pragmatic alternative in settings where access to advanced diagnostic tools is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.